Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone/Salmeterol vs Fluticasone in Pediatric Activity-Induced Bronchospasm
NCT00118690Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2003
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol in exercise-induced bronchospasm (EIB), sponsored by GSK. Started Dec 2003; status: completed.
02
Drugs
salmeterol
03
Conditions
exercise-induced bronchospasm (EIB)
Beyond the preview
Go deeper on NCT00118690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118690.